Hill NL, Mogle J, Bhargava S, Bratlee-Whitaker E, Wion RK, Sweeder L, Sliwinski M, Barnes LL. Within-person associations among self-perceptions of memory, depressive symptoms, and activity participation in older adults. Gerontologist. 2021 Sep 13;61(7):1107-17. doi: 10.1093/geront/gnaa208
Hill NL, Mogle J, Whitaker EB, Gilmore-Bykovskyi A, Bhargava S, Bhang IY, Sweeder L, Tiwari PA, Van Haitsma K. Sources of response bias in cognitive self-report items: "Which memory are you talking about?". Gerontologist. 2019 Sep 17;59(5):912-24. doi: doi.org/10.1093/geront/gny087
Wilson M, Lucas A, Cameron A, Luo M. Budget impact of adding vedolizumab to a health plan formulary as a first-line biologic option for ulcerative colitis and crohn's disease. Am Health Drug Benefits. 2018 Jul;11(5):253-62.
Gomersall T, Spencer S, Basarir H, Tsuchiya A, Clegg J, Sutton A, Dickinson K. Measuring quality of life in children with speech and language difficulties: a systematic review of existing approaches. Int J Lang Commun Disord. 2015 Jul;50(4):416-35. doi: 10.1111/1460-6984.12147
Harris JB, Ward MA, Schwab P. Is response-guided therapy being applied in the clinical setting? The hepatitis C example. Am Health Drug Benefits. 2015 Feb;8(1):22-8.
Sacco P, Capkun-Niggli G, Zhang X, Jose R. The economic burden of fragile x syndrome: healthcare resource utilization in the United States. Am Health Drug Benefits. 2013 Mar;6(2):73-83.
Lennert B, Bibeau W, Farrelly E, Sacco P, Schoor T. Assessment of treatment patterns and patient outcomes in levodopa-induced dyskinesias (ASTROID): a US chart review study. Am Health Drug Benefits. 2012 Sep;5(6):347-58.